Abstract
The pathogenesis of breast cancer is profoundly influenced by the signaling cascades downstream of the human epidermal growth factor receptor (HER; also known as the ErbB receptor) family of receptor tyrosine kinases and by the HER ligands ([1][1], [2][2]). Abnormalities in the expression and
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have